GLP-1 fatigue: patients who have cycled on and off semaglutide and tirzepatide are looking for alternatives that address body composition without the side effect profile of GLP-1 agonists
Treatment decisions are made deliberately based on medical screening, candidacy, and long-term planning, and not marketing trends
GLP-1RA use was associated with a reduced risk of neurocognitive disorders (e.g., dementia and Alzheimers disease), seizures, thromboembolic disorders, pulmonary hypertension, chronic phlebitis, coagulopathy, and clotting disorders
My goal is always to ensure that the product performs the same way from the first drop to the last, because consistency is what ultimately drives repeat purchases
Given the ancient origin of the Ca 2+ -based signaling, which evolutionary developed earlier than the mitochondrial apoptotic toolkit whose emergence cannot be dated back to the times earlier than eukaryogenesis and acquisition of an endosymbiotic mitochondrion, it can be assumed that the Ca 2+ toolkit takes over a key role in cell death signaling in terminally differentiated mitochondria-free erythrocytes
The CDMO market responded simultaneously